Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier
- 1 August 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 293 (2), F501-F505
- https://doi.org/10.1152/ajprenal.00131.2007
Abstract
This study examined the metabolism of arachidonic acid (AA) by cytochrome P-450 enzymes in isolated glomeruli and the effects of selective inhibitors of the synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatetraenoic acids (EETs) on glomerular permeability to albumin ( Palb). Glomeruli avidly produced 20-HETE, EETs, dihydroxyeicosatetraenoic acids (diHETEs), and HETEs when incubated with exogenous AA. N-hydroxy- N′-(4-butyl-2-methylphenyl)formamidine (HET0016; 10 μM) selectively inhibited the formation of 20-HETE by 95% and increased Palbfrom 0.00 ± 0.08 to 0.73 ± 0.10 ( n = 43 glomeruli, 4 rats). Addition of a 20-HETE mimetic, 20-hydroxyeicosa-5( Z),14( Z)-dienoic acid (20-5,14-HEDE; 1 μM) opposed the effects of HET0016 (10 μM) to increase Palb(0.21 ± 0.10, n = 36 glomeruli, 4 rats). Preincubation of glomeruli with exogenous AA to increase basal production of 20-HETE had a similar effect. We also examined the effect of an epoxygenase inhibitor, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MSPPOH; 5 μM), on Palb. MSPPOH (5 μM) significantly increased Palbbut had no effect on the synthesis of EETs in glomeruli incubated with AA. However, MSPPOH (5 μM) selectively reduced epoxygenase activity by 50% in glomeruli incubated without added AA. Pretreatment with 8,9-EET (100 nM) attenuated the effects of MSPPOH (5 μM) on Palb. These results indicate that glomeruli produce 20-HETE, EETs, diHETEs, and HETEs and that endogenously formed 20-HETE and EETs play an essential role in the maintenance of the glomerular permeability barrier to albumin.Keywords
This publication has 33 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor-α Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor BlockadeHypertension, 2005
- Transforming Growth Factor-β, 20-HETE Interaction, and Glomerular Injury in Dahl Salt-Sensitive RatsHypertension, 2005
- Fenofibrate Prevents the Development of Angiotensin II–Dependent Hypertension in MiceHypertension, 2005
- Vascular localization of soluble epoxide hydrolase in the human kidneyAmerican Journal of Physiology-Renal Physiology, 2004
- Impaired Renal Autoregulation: Implications for the Genesis of Hypertension and Hypertension-Induced Renal InjuryThe American Journal of the Medical Sciences, 2001
- Transforming growth factor-β1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicalsKidney International, 2000
- Fenofibrate lowers blood pressure in two genetic models of hypertensionCanadian Journal of Physiology and Pharmacology, 2000
- Modulation of glomerular hypertension defines susceptibility to progressive glomerular injuryKidney International, 1994
- Glomerular hypertension and injury in desoxycorticosterone–salt rats on antihypertensive therapyKidney International, 1987
- Two-Kidney, One Clip Renal Hypertension in the MarmosetJournal Of Hypertension, 1986